Application of immunosuppressant facilitates the therapy of optic neuritis combined with Sj(o)gren's syndrome
- Author:
- No author available
- Journal Title:
- Chinese Medical Journal
- Issue:
- 17
- DOI:
- 10.3760/cma.j.issn.0366-6999.20133253
- Key Word:
- optic neuritis;Sj(o)gren's syndrome;magnetic resonance imaging;immunosuppressant;remedy
Abstract： Background Optic neuritis (ON) is often the first symptom of multiple sclerosis (MS) and neuromyelitis optica (NMO) while there has been very little research reported on ON combined with Sj(o)gren's syndrome (SS).The aim of this study is to provide different treatments and services for and NMO patients combined with SS.Methods Twenty-seven patients with ON combined SS were divided into two groups:corticosteroid group (C group,methylprednisolone sodium succinate,14 patients) and corticosteroid+ immunosuppressant group (C+I group,leflunomide,13 patients).ON relapse times in 1 year after treatment,number of patients who relapsed to NMO/MS in 1 years,visual acuity and retina nerve fiber layer (RNFL) thickness were measured.Mann Whitney-Wilcoxon test was used to compare continuous variables and Chi-square test or Fisher's exact test was to compare proportions.Results ON combined with SS patients had higher incidence rates in middle-aged women who have binocular damage and heavier visual function damage or when there is an easy relapse,and the patients are often hormone dependent.The patients are more likely anti-aquaporin-4 IgG seropositive (70.4％).They are liable to form a centrocecal scotoma and tubular vision.The times of relapse decreased in patients who used immunosuppressant,and a significant difference was found between immunosuppressant and non-immunosuppressant groups in visual acuity recovery during 6-month followup period (P ＜0.05); however,the RNFL thickness at the four quadrants was not significantly different.Conclusions The effect of immunosuppressant plus corticosteroid on the early onset of ON combined with SS was to provide ON remedy and to prevent recurrence in clinics.This study provides a significant reference for the prevention and treatment of ON on the basis of immunosuppressant and corticosteroid.
- [1]Massara A,Bonazza S,Castellino G,etc.Central nervous system involvement in Sjogren's syndrome: unusual, but not unremarkable--clinical, serological characteristics and outcomes in a large cohort of Italian patients.[J].2010,49(8).
- [2]Kurne A,Calguneri M,Karlioguz K,etc.A clinically isolated syndrome: A challenging entity: Multiple sclerosis or collagen tissue disorders: Clues for differentiation.[J].2008,255(11).
- [3]Peen E,Mellbye OJ,Haga HJ.IgA rheumatoid factor in primary Sjogren's syndrome.[J].2009,38(1).
- [4]Miller D,Chard D.Is multiple sclerosis a generalized disease of the central nervous system? An MRI perspective.[J].2009,22(3).
- [5]T, Witte.[Reviewed for you: new criteria of Sj?gren's syndrome].[J].2013,72(3).
- [6]Wingerchuk DM,Lennon VA,Pittock SJ,etc.Revised diagnostic criteria for neuromyelitis optica.[J].2006,66(10).
- [7]Pantoni, Leonardo.Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges[J].2010,9(7).
- [8]te Boome L,Zandbelt M,Klasen I.Tear fluid measurement of anti-SS-A and anti-SS-B antibody in anti-SS-A and anti-SS-B seronegative Sjogren's syndrome patients.[J].2009,27(3).
- [9]Rose, N.,Anoop, T.M.,John, A.P.,etc.Acute optic neuritis following infection with chikungunya virus in southern rural India[J].2011,15(2).
- [10]Sandberg-Wollheim M.,Axellm T.,Hansen B. U.,etc.Primary Sjogren's syndrome in patients with multiple sclerosis[J].1992.
- [11]Durdane, Aksoy,Erkan, Gokce,Semiha, Kurt,etc.Subclinical optic neuritis in neuromyelitis optica.[J].2013,33.
- [12]W M, Budde,S, Schober,M, Küchle.[Optic nerve neuritis after 50 years of age: symptom of a previously undiagnosed multiple sclerosis].[J].1997,211(1).
- [13]Yang,Y.,Li,Z.,Wang,L.,etc.The clinical and laboratory characteristics of Sj?gren's syndrome that progresses to systemic lupus erythematosus: A retrospective case-control study[J].2013,16(2).
- [14]Dubucquoi S,Hatron PY,Vermersch P,etc.Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients.[J].2004,83(5).
- [15]Scofield,R.H.,Igoe,A..Autoimmunity and infection in Sj?gren's syndrome[J].2013,25(4).
- [16]Burman J,Fagius J,Raininko R.Bilateral and recurrent optic neuritis in multiple sclerosis.[J].2011,123(3).
- [17]Vissink,A.,Spijkervet,F.K.L.,Kroese,F.G.M.,etc.Toward new classification criteria for Sj?gren's syndrome?[J].2013,65(1).
- [18]Chan,J.W..Recent advances in optic neuritis related to multiple sclerosis[J].2012,90(3).
- [19]Bikker,A.,VanWoerkom,J.-M.,Kruize,A.A.,etc.Clinical ef cacy of le unomide in primary Sj gren s syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression[J].2012,71(12).
- [20]He,J.,Ding,Y.,Feng,M.,etc.Characteristics of Sj?gren's syndrome in rheumatoid arthritis[J].2013,52(6).
- [21]Schulze Koops H.Restriction of De Novo Pyrimidine Biosynthesis Inhibits Th1 Cell Activation and Promotes Th2 Cell Differentiation.[J].2002,169(6).
- [22]Pavel, Diblík,D, Horáková.[Optic neuritis in multiple sclerosis].[J].2010,66(2).
- [23]Wahl GM,Strand V,Fox RI,etc.Mechanism of action for leflunomide in rheumatoid arthritis.[J].1999,93(3).
- [24]L A, Sedwick,T G, Klingele,R M, Burde,etc.Optic neuritis in inflammatory bowel disease.[J].1984,4(1).
- [25]E K, Chan,L E, Andrade.Antinuclear antibodies in Sj?gren's syndrome.[J].1992,18.
- [26]Nielsen NM,Jorgensen KT,Pedersen BV,etc.The co-occurrence of endometriosis with multiple sclerosis, systemic lupus erythematosus and Sjogren syndrome.[J].2011,26(6).
- [27]Takagi K,Tochimoto A,Okamoto Y,etc.Clinical manifestations of neurological involvement in primary Sjogren's syndrome.[J].2011,30(4).
- [28]Lazzaro M,Blair EA,Pytel P,etc.Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis.[J].2008,14(6).
- [29]Vera D, Milic,Goran, Radunovic,Ivan, Boricic,etc.High prevalence of autoimmune thyroid disease in subjects with sicca symptoms without Sjogren's syndrome.[J].2013,52.